Lu Roujian について
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China について
Zhao Xiang について
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China について
Li Juan について
Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University and Shandong Academy of Medical Sciences, Tai’an, China について
Niu Peihua について
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China について
Yang Bo について
Division for Viral Disease Detection, Hubei Provincial Center for Disease Control and Prevention, Wuhan, China について
Wu Honglong について
BGI PathoGenesis Pharmaceutical Technology, Shenzhen, China について
Wang Wenling について
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China について
Song Hao について
Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China について
Huang Baoying について
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China について
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China について
Bi Yuhai について
Chinese Academy of Sciences Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China について
Bi Yuhai について
Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing, China について
Ma Xuejun について
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China について
Zhan Faxian について
Division for Viral Disease Detection, Hubei Provincial Center for Disease Control and Prevention, Wuhan, China について
Wang Liang について
Chinese Academy of Sciences Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China について
Wang Liang について
Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing, China について
Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University and Shandong Academy of Medical Sciences, Tai’an, China について
Zhou Hong について
Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University and Shandong Academy of Medical Sciences, Tai’an, China について
Hu Zhenhong について
Central Theater, People’s Liberation Army General Hospital, Wuhan, China について
Zhou Weimin について
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China について
Zhao Li について
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China について
Chen Jing について
Key Laboratory of Laboratory Medicine, Ministry of Education, and Zhejiang Provincial Key Laboratory of Medical Genetics, Institute of Medical Virology, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China について
Meng Yao について
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China について
Wang Ji について
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China について
Lin Yang について
BGI PathoGenesis Pharmaceutical Technology, Shenzhen, China について
Yuan Jianying について
BGI PathoGenesis Pharmaceutical Technology, Shenzhen, China について
Xie Zhihao について
BGI PathoGenesis Pharmaceutical Technology, Shenzhen, China について
Ma Jinmin について
BGI PathoGenesis Pharmaceutical Technology, Shenzhen, China について
Liu William J について
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China について
Wang Dayan について
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China について
Xu Wenbo について
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China について
Holmes Edward C について
Marie Bashir Institute for Infectious Diseases and Biosecurity, School of Life and Environmental Sciences and School of Medical Sciences, University of Sydney, Sydney, NSW, Australia について
Gao George F について
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China について
Gao George F について
Chinese Academy of Sciences Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China について
Gao George F について
Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing, China について
Wu Guizhen について
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China について
Chen Weijun について
BGI PathoGenesis Pharmaceutical Technology, Shenzhen, China について
Shi Weifeng について
Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University and Shandong Academy of Medical Sciences, Tai’an, China について
Shi Weifeng について
The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital), Jinan, China について
Tan Wenjie について
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China について
Tan Wenjie について
Central Theater, People’s Liberation Army General Hospital, Wuhan, China について
Tan Wenjie について
Center for Biosafety Mega-Science, Chinese Academy of Sciences, Beijing, China について
Lancet について
ゲノム について
微生物 について
配列相同性 について
cDNA について
疫学 について
コウモリ について
受容体 について
気管支肺胞洗浄液 について
遺伝 について
動物 について
病原体 について
太陽コロナ について
ヒト について
ウイルス性肺炎 について
感染症 について
感染症・寄生虫症一般 について
コロナウイルス について
ゲノム について
特性化 について
疫学 について
ウイルス について
起源 について
受容体結合 について
意味 について